Impact and Safety of Adjuvant Chemotherapy on Pulmonary Function in Early Stage Non-Small Cell Lung Cancer
Author(s) -
Michael Kreuter,
Johan Vansteenkiste,
Felix J.F. Herth,
Jürgen R. Fischer,
Wilfried Eberhardt,
I. Zuna,
Niels Reinmuth,
Frank Griesinger,
Mike Thomas
Publication year - 2013
Publication title -
respiration
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.264
H-Index - 81
eISSN - 1423-0356
pISSN - 0025-7931
DOI - 10.1159/000355361
Subject(s) - medicine , lung cancer , pulmonary function testing , chemotherapy , gastroenterology , vinorelbine , pemetrexed , cisplatin
Pulmonary function may decline after induction chemotherapy and predict perioperative complications in non-small cell lung cancer (NSCLC). The influence of adjuvant chemotherapy is largely indeterminate.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom